Rubella: Lanka`s dilemma

  • 21 Oct 2009 17:42:35 GMT

    [ The government says it has initiated an investigation again ]

    BS to fool the public. they should have done this when the first individual died.

  • 21 Oct 2009 17:46:17 GMT

    [ But, the WHO is of the view that the vaccine meets its standards and the supplier is registered with it. ]

    This is true. WHO can not do anything except saying this.

    Even the SLBC advertise that the same drug brought from UK to be superior than the same brought from India. that can not be as all those approved by regulatory authorities.

    IF the exact Vaccine batch is released, GOSL has to study what component cause this anaphylactic reaction and what percentage of the population is vulnerable to that.

    Just the way they use penicillin, they need to stay away from giving it to vulnerable individuals.

    IT is not true that Indian stuff is low quality. Actually, at present, India is very good and Sri Lanka should work hard to get some of the GENERIC Pharmaceutical manufacturing to Sri Lanka to cut cost of importing.

  • 22 Oct 2009 12:05:16 GMT

    Patent rights regulations has made the Indian Market less attractive for foreign companies.

    Quality of Indian Medicines.

    Counterfeit drugs could be the single biggest problem in India in the next ten years due to the growth of garage-based drug manufacturing outfits, rampant corruption, and weak drug control, A 2003 Scrip report estimated that 15 to 20% of the medicines sold in the country are counterfeits. A case study reported in a 2001 conference showed the following percentage (out of 125 tracer medicines) that failed quality testing: 6% from the public sector, 12.7% from the private sector and 0% from NGOs.

    In 2001, Lancet reported that, according to WHO statistics, India produces as much as 35% of the fake and substandard drugs in the world. A powerful group of manufacturers have taken over much of the production during the past three years. It is reported that these Counterfeit drugs are manufactured mostly in the northern states but these fake drugs are widely available throughout the country. They are available as well in Myanmar (Burma) and Cambodia, and their distribution may even extend as far as the former Soviet states, as evidenced by the arrest of four Uzbek women caught trying to smuggle them to be sold in their country. (Ref: 2004 The United States Pharmacopeial Convention, Inc. A Review of Drug Quality in Asia with Focus on Anti-Infective).

    India was among the six countries that participated in a drug quality study which collected a total of 71 samples of the antituberculosis drugs isoniazid (INH) and rifampicin (RMP) as a single entity or a fixed-dose combination (FDC) (see Multi-country studies). Overall, 10% (4/40) of all samples obtained from all six countries, including 13% (4/30) RMP were substandard, containing - 85% of stated content. More FDCs, 21% (5/24), than single drug samples, 13% (2/16), were deemed substandard.

  • 22 Oct 2009 12:10:25 GMT


    Quality of Chinese Medicines:

    According to the SDA, a nation-wide survey on the quality of medicines carried out in 1998 found that 13.1% of the 20,000 batches tested were either counterfeit or fell below minimal pharmaceutical standards.

    In 1997, China News Digest reported that the Health Ministry of China inspected 1100 medicines and found 138 products that failed to meet national standards. Of these, 48 were fake medicines with pirated registration numbers.

    At the 2002 Global Forum on Pharmaceutical Anti counterfeiting held in Geneva, Switzerland, a representative from the Glaxo SmithKline (GSK) pharmaceutical company reported on the counterfeiting of two of their products in China. The first was Imuran tablets. The counterfeit Imuran was found to contain the correct amount of azathioprine, the active ingredient however, the tablets were labeled incorrectly as azathiopring. Upon testing, the tablets failed the quality specification for disintegration time. The tablets were still intact after four hours in water at 37 C, while genuine tablets dissolve in 45 minutes. The other drug was Zinacef tablets. The genuine oral dosage form contains cefuroxime axetil the counterfeit Zinacef tablets revealed the presence of cefuroxime sodium, the injectable dose form. When taken orally, cefuroxime sodium is absorbed minimally by the digestive system resulting in no therapeutic benefit.



  • 22 Oct 2009 12:13:27 GMT


    From all above analysis it is clear that importing Drugs from these countries will be not only harmful for the economy but also dangerous for the health and safety of the nation.

    Therefore, it is needed to restrict import of Low Quality Finished products specially from India and China or any other country by levying Protection duties on products which are produced locally and measures should be taken to improve growth of Local Pharmaceuticals as well as to promote exports of Pharmaceuticals.



  • 23 Oct 2009 18:27:13 GMT

    [From all above analysis it is clear that importing Drugs from these countries will be not only harmful for the economy but also dangerous for the health and safety of the nation.


    In the west some times, sub standard lots are recalled.

    Some times recalled because of tampering.

    Pakistan, Just like sri Lanka can not manufacture even counterfeit pharmaceuticals.

  • 24 Oct 2009 09:32:58 GMT


    I suppose what you are suggesting is that the GoSL import drugs of the highest quality from Pakistan only.